Publications by Dr Jonathan Wallis - ePrints

Browsing publications by Dr Jonathan Wallis.

Newcastle Authors	Title	Year
Erhan Aptullahoglu Dr Sirintra Nakjang Dr Jonathan Wallis Dr Helen Marr Dr Scott Marshall et al.	RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia	2024
Erhan Aptullahoglu Dr Jonathan Wallis Dr Helen Marr Dr Elaine Willmore Professor John Lunec et al.	SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia	2023
Dr Evan Mulligan Dr Susan Tudhope Dr Jill Hunter Sarah Elliott Dr Jonathan Wallis et al.	Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling	2023
Dr Carmela Ciardullo Dr Jonathan Wallis Dr Helen Marr Dr Nicholas Bown Dr Elaine Willmore et al.	Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition	2023
Dr Timothy Barrow Dr Sirintra Nakjang Kateryna Bilotkach Dr Laura Woodhouse Gesa Junge et al.	Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia	2021
Eoin Moloney Dr Joy Allen Dr Peter Carey Dr Louise Johnston Rachel O'Leary et al.	Efficiency and Health Economic Evaluations of BD OneFlow™ Flow Cytometry Reagents for Diagnosing Chronic Lymphoid Leukemia	2019
Dr Carmela Ciardullo Erhan Aptullahoglu Dr Laura Woodhouse Dr Wei-Yu Lin Dr Jonathan Wallis et al.	Non-genotoxic MDM2 inhibition selectively induces pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells	2019
Dr Jonathan Wallis	A transfusion prescription template and other human factor interventions to improve balanced transfusion delivery in major haemorrhage due to trauma	2018
Dr Jonathan Wallis	Age of platelet concentrates and time to the next transfusion	2018
Dr Timothy Barrow Dr Laura Woodhouse Gesa Junge Dr Susan Tudhope Dr Jonathan Wallis et al.	The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy	2016
Professor Andrew Gennery Dr Jonathan Wallis	ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titers	2015
Dr Elaine Willmore Dr Aaron Ions Gardner Dr Susan Tudhope Belinda Murtani Jessica Caffry et al.	Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells	2015
Dr Ashleigh Herriott Dr Susan Tudhope Gesa Junge Natalie Rodrigues Dr Miranda Patterson et al.	PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia	2015
Dr Jonathan Wallis	Variant CJD and blood transfusion	2015
Dr Jonathan Wallis Dr Gail Jones	Alloantibody formation in the frequently transfused haemato-oncology patient - an audit of alloimmunisation rates and the cost effectiveness of a 'proactive versus reactive' transfusion regimen	2014
Dr Stephen Wright Dr Christopher Snowden Dr Jonathan Wallis	Cardiopulmonary exercise testing before and after blood transfusion: a prospective clinical study	2014
Dr Jonathan Wallis	Familial pseudohyperkalemia in blood donors: A novel mutation with implications for transfusion practice	2014
Dr Samuel Moses Professor Stephen O'Brien Dr Tobias Menne Dr Jonathan Wallis	Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia	2014
Dr Jonathan Wallis	Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)	2014
Dr Jonathan Wallis	Ten-year pattern of red blood cell use in the North of England	2013
Dr Jonathan Wallis Dr R Neely	An unusual case of secondary hyperlipidaemia	2012
Dr Samuel Moses Professor Stephen O'Brien Dr Tobias Menne Dr Jonathan Wallis	Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia	2012
Dr Elaine Willmore Natalie Rodrigues Dr Jonathan Wallis Professor Nicola Curtin	High Activity of Poly(ADP-Ribose) Polymerase in Chronic Lymphocytic Leukemia	2012
Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang Dr Rachel Dickinson Dr Naomi McGovern et al.	Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation	2011
Dr Jonathan Wallis	Disentangling anemia and transfusion	2011
Dr Rachel Dickinson Dr Helen Griffin Dr Venetia Bigley Dr Louise Reynard Raf Hussain et al.	Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency	2011
Dr Rachel Dickinson Dr Venetia Bigley Dr Helen Griffin Professor Jeremy Lakey Dr Naomi McGovern et al.	Human dendritic cell deficiency is caused by GATA-2 mutation	2011
Dr sarah Johnson Clark Crawford Dr Evan Mulligan Dr Jonathan Wallis Dr Tryfonia Mainou-Fowler et al.	Mitoxantrone in combination with an inhibitor of DNA-dependent kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia	2011
Dr Katherine Sturgess Professor Mary Slatter Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang et al.	Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation	2011
Dr Venetia Bigley Dr Xiao Wang Dr Rachel Dickinson Dr Naomi McGovern Sarah Pagan et al.	The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency	2011
Dr Evan Mulligan Arabella Baird Dr Jonathan Wallis Dr Stephany Veuger Professor barbara Durkacz et al.	Relationships Between Aberrant Activity of the NF-kappa B Subunits and Outcome In Chronic Lymphocytic Leukemia: The Dual Role of DNA Damage Sensor Enzymes	2010
Dr Jonathan Wallis Dr ROGER Jay	Transfusion, discharge, haemoglobin, and readmission or death after hip fracture [abstract]	2010
Dr Jonathan Wallis	How much residual plasma may cause TRALI?	2008
Dr Jonathan Wallis	Reply to Ballard et al. [2]	2007
Dr Jonathan Wallis	[abstract] TRALI at Freeman Hospital since the introduction of male donor only fresh frozen plasma	2006
Dr Jonathan Wallis	Changing indications for red cell transfusion from 2000 to 2004 in the North of England	2006
Phil Botha Dr Jonathan Wallis	Exchange transfusion during extra corporeal membrane oxygenation used as a bridge to ABO-mismatch cardiac transplantation	2006
Dr Jonathan Wallis	Preventing ABO incompatible blood transfusion	2006
Dr Jonathan Wallis Dr Peter Hamilton	Effect of storage age of transfused blood on 48 hour Hb increment and recovery of 2,3 DPG in haematology patients	2005
Dr Jonathan Wallis	Nitric oxide and blood: a review	2005
Dr Jonathan Wallis	Recovery from post-operative anaemia	2005
John Hamilton Dr Jon Smith Dr Jonathan Wallis Dr Patrick Kesteven Dr John O'Sullivan et al.	ABO-incompatible heart transplantation in infants: The Freeman Hospital experience	2004
Dr Jonathan Wallis	Is fresh frozen plasma overtransfused in the United States?	2004
Dr Jonathan Wallis Professor John Matthews	Long-term survival after blood transfusion: a population based study in the North of England	2004
Dr Jonathan Wallis	Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation	2004
Dr Jonathan Wallis	Leukoreduction vs buffy-coat depletion and the safety of blood transfusion	2003
Dr Jonathan Wallis	Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child	2003
Dr Jonathan Wallis	Single hospital experience of TRALI	2003
Dr Jonathan Wallis	'Tag and label' system for checking and recording of blood transfusions	2003
Dr Jonathan Wallis	Transfusion-related acute lung injury (TRALI) - under-diagnosed and under-reported	2003
Dr Jonathan Wallis	Audit of red cell transfusion	2002
Dr Jonathan Wallis Dr John Hanley	Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity	2002
Dr Jonathan Wallis Dr Katherine Orr	Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery	2002
Dr Jonathan Wallis	Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion	2002
Dr Mohamed Khadra Dr Jonathan Wallis Professor David Neal	Vitamin B12 malabsorption following bladder reconstruction or diversion with bowel segments	2002
Dr Jonathan Wallis	Where does blood go? Prospective observational study of red cell transfusion in north England	2002
Dr Susan Jackson Dr Jonathan Wallis	Coagulation factor activity during neonatal extra-corporeal membrane oxygenation	2001
Dr Jonathan Wallis Katharine Rogers	Loss of platelet inhibitory activity of nitrosoglutathione in plasma is pH dependent	2001
Dr Jonathan Wallis	Is it time to give up the crossmatch?	2000
Dr Jonathan Wallis	Transfusion-related acute lung injury	2000
Dr Gavin Spickett Dr Jonathan Wallis Dr Peter Saunders	Northern Region asplenia register - analysis of first two years	1999
Dr Jonathan Wallis	Transfusion-related acute lung injury	1999
Dr Michael Reid Dr Jonathan Wallis Professor Andrew Pearson Professor Archibald Malcolm	Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma	1991
Professor Graham Jackson Dr Jonathan Wallis Dr Anne Lennard Professor Stephen Proctor	Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia	1990